Investors should monitor pipeline updates, FDA approvals, early generic launches or legal rulings, and policy developments like Medicare negotiation specifics
Roughly 70 percent of those papers come from a single research group in Croatia, led by a scientist named Predrag Sikiric, who has spent his entire career on this one molecule
Then Mounjaro, which is a different drug from a different company that actually not only has GLP-1 agonist effects, but also GIP gastrointestinal polypeptide, which delays stomach emptying a little bit and has been shown to be more effective for weight loss
thaliana GST genes, which participate in defense reactions (De Vos et al., cis -elements that bind WRKY transcription factors (Eulgem and Somssich, A